Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100505817 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DCAF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM199X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERLEC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGGT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOXHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on